Cerebrospinal fluid (CSF)-based molecular tests can reliably distinguish multiple sclerosis (MS) from other neurological conditions, according to a new study that analyzed cryopreserved CSF samples ...

The Europe in-vitro diagnostics market size was valued at USD 29.13 billion in 2025 and is predicted to hit around USD 48.92 ...

Co-Diagnostics, Inc. (OTC: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it ...

The renewed and expanded agreements provide improved commercial conditions, including more competitive pricing, optimized ...

In recent times, investors have been increasingly drawn to companies operating in the molecular diagnostics space, a rapidly growing segment within the broader in-vitro diagnostics (IVD) market.

Antimicrobial resistance (AMR) represents one of the most pressing global health challenges of the 21st century, threatening the effectiveness of treatments and burdening healthcare systems worldwide.

Company and CoSara believe that ISO certification is a critical component of the regulatory requirements for clearance of new ...

In Lake Success, Northwell Health‘s Cancer Institute’s Center for Genomic Medicine has opened a $3.2 million Molecular Diagnostics Laboratory, or MDL. The 2,800-square-foot facility is designed to ...

When Domain Associates led Xagenic Inc.’s recent $20 million Series B, it marked the eighth diagnostics investment the firm had made with its $500 million eighth fund. The partners say they’ve ...

CDSCO license on Form MD-5 authorizes CoSara to manufacture PCR Pro instrument in its Ranoli, India facility for sale or ...

ALIGARH, Feb. 5 -- Private Partnership (PPP) with Molecular Diagnostics and Therapy LLP to establish a state-of-the-art Oncology and Advanced Diagnostic Centre at the Cancer OPD block, Department of ...

TORINO, Italy--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) is pleased to announce the closing of its acquisition of ELITechGroup (“ELITech”) for €870 million in cash, excluding the carved out ...